Literature DB >> 16023355

Thalamic nicotinic receptors implicated in disturbed consciousness in dementia with Lewy bodies.

Sally L Pimlott1, Margaret Piggott, Clive Ballard, Ian McKeith, Robert Perry, Simon Kometa, Jonathan Owens, David Wyper, Elaine Perry.   

Abstract

Disturbances of consciousness (DOC) are common in dementia with Lewy bodies (DLB). Following previous findings of preserved temporal cortical high-affinity nicotinic binding relating to DOC, we investigated this receptor in thalamus, an area of high nicotinic receptor concentration, implicated in consciousness. 5-[125I]-A-85380 binding, primarily reflecting the alpha4beta2 subtype, was compared in 16 DLB patients with DOC and 6 without DOC, matched for duration and severity of dementia. Binding was higher in patients with DOC compared to patients without DOC in all thalamic nuclei examined, reaching significance in the reticular and ventral anterior thalamic nuclei. Comparing DLB patients with and without DOC to previously reported controls revealed similar binding levels in patients with DOC and lower binding in patients without DOC, reaching significance in the ventral anterior, indicating preserved nicotinic receptor density in DLB patients with DOC. These findings, together with previous neocortical data, implicate nicotinic modulation of thalamo-cortical circuitry as a key component in the control of conscious awareness in DLB.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023355     DOI: 10.1016/j.nbd.2005.06.008

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  8 in total

1.  Nicotinic Acetylcholine Receptor Density in the "Higher-Order" Thalamus Projecting to the Prefrontal Cortex in Humans: a PET Study.

Authors:  Valentina Garibotto; Michael Wissmeyer; Zoi Giavri; Osman Ratib; Fabienne Picard
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Focal atrophy in dementia with Lewy bodies on MRI: a distinct pattern from Alzheimer's disease.

Authors:  Jennifer L Whitwell; Stephen D Weigand; Maria M Shiung; Bradley F Boeve; Tanis J Ferman; Glenn E Smith; David S Knopman; Ronald C Petersen; Eduardo E Benarroch; Keith A Josephs; Clifford R Jack
Journal:  Brain       Date:  2007-01-31       Impact factor: 13.501

3.  Thalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance Evidences.

Authors:  Stefano Delli Pizzi; Raffaella Franciotti; John-Paul Taylor; Astrid Thomas; Armando Tartaro; Marco Onofrj; Laura Bonanni
Journal:  Cereb Cortex       Date:  2014-09-26       Impact factor: 5.357

4.  Dysfunctional brain dynamics and their origin in Lewy body dementia.

Authors:  Julia Schumacher; Luis R Peraza; Michael Firbank; Alan J Thomas; Marcus Kaiser; Peter Gallagher; John T O'Brien; Andrew M Blamire; John-Paul Taylor
Journal:  Brain       Date:  2019-06-01       Impact factor: 13.501

Review 5.  The Pharmacology of Visual Hallucinations in Synucleinopathies.

Authors:  Mirella Russo; Claudia Carrarini; Fedele Dono; Marianna Gabriella Rispoli; Martina Di Pietro; Vincenzo Di Stefano; Laura Ferri; Laura Bonanni; Stefano Luca Sensi; Marco Onofrj
Journal:  Front Pharmacol       Date:  2019-12-09       Impact factor: 5.810

6.  Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in dementia with Lewy bodies.

Authors:  John-Paul Taylor; Sean J Colloby; Ian G McKeith; John T O'Brien
Journal:  Int Psychogeriatr       Date:  2013-10-23       Impact factor: 3.878

7.  Structural grey matter changes in the substantia innominata in Alzheimer's disease and dementia with Lewy bodies: a DARTEL-VBM study.

Authors:  Sean J Colloby; Greg J Elder; Riham Rabee; John T O'Brien; John-Paul Taylor
Journal:  Int J Geriatr Psychiatry       Date:  2016-05-19       Impact factor: 3.485

8.  Changes in gray matter volume and functional connectivity in dementia with Lewy bodies compared to Alzheimer's disease and normal aging: implications for fluctuations.

Authors:  Eléna Chabran; Vincent Noblet; Paulo Loureiro de Sousa; Catherine Demuynck; Nathalie Philippi; Catherine Mutter; Pierre Anthony; Catherine Martin-Hunyadi; Benjamin Cretin; Frédéric Blanc
Journal:  Alzheimers Res Ther       Date:  2020-01-06       Impact factor: 6.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.